Treatment with KD025 resulted in decreased MYC protein levels in the ABC-DLBCL cells examined, while no significant changes in MYC transcription were observed at these time points (Figs. 5f, S4D). The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.